Trials / Completed
CompletedNCT05419466
Kinetic of Compounds of a Melatonin-based Formulation in Healthy Subjects
Kinetic of Plasmatic Compounds and Metabolites of a Melatonin-based Formulation in Healthy Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Larena SAS · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is conducted to clinically document the melatonin and zinc bioavailability of a dietary supplement containing delayed release melatonin, zinc and lemon balm
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | dietary supplement, 1 tablet containing delayed release melatonin, zinc and lemon balm | dietary supplement is dosed at 1.9 mg of melatonin, 10 mg of zinc and 200 mg of lemon balm for one tablet |
Timeline
- Start date
- 2023-03-14
- Primary completion
- 2023-05-22
- Completion
- 2023-05-22
- First posted
- 2022-06-15
- Last updated
- 2023-11-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05419466. Inclusion in this directory is not an endorsement.